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Abstract
Background: Diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome or ME/CFS is largely based on
clinical history, and exclusion of identifiable causes of chronic fatigue. Characterization of cases and the impact of
interventions have been limited due to clinical heterogeneity and a lack of reliable biomarkers for diagnosis and
outcome measures. People with ME/CFS (PWME) often report high levels of disability, which are difficult to
measure objectively. The well being of family members and those who care for PWME are also likely to be
affected. This study aimed to investigate the functional status and well being of PWME and their lay carers, and to
compare them with people with other chronic conditions.
Methods: We used a cross sectional design to study 170 people aged between 18 and 64 years with well
characterized ME/CFS, and 44 carers, using SF-36 v2™. Mean physical and mental domains scores (scales and
component summaries) were calculated and compared internally and externally with reference standards for the
general population and for population groups with 10 chronic diseases.
Results: SF-36 scores in PWME were significantly reduced, especially within the physical domain (mean norm-
based Physical Component Summary (PCS) score = 26.8), but also within the mental domain (mean norm-based
score for Mental Component Summary (MCS) = 34.1). The lowest and highest scale scores were for “Role-Physical”
(mean = 25.4) and “Mental Health” (mean = 36.7) respectively. All scores were in general lower than those for the
general population and diseased-specific norms for other diseases. Carers of those with ME/CFS tended to have
low scores in relation to population norms, particularly within the mental domain (mean = 45.4).
Conclusions: ME/CFS is disabling and has a greater impact on functional status and well being than other chronic
diseases such as cancer. The emotional burden of ME/CFS is felt by lay carers as well as by people with ME/CFS.
We suggest the use of generic instruments such as SF-36, in combination of other objective outcome
measurements, to describe patients and assess treatments.
Background
The diagnosis of myalgic encephalomyelitis/chronic fati-
gue syndrome (ME/CFS) requires the presence for over 6
months of fatigue and other symptoms, and restriction of
the ability of those affected to sustain previous levels of
social, work and leisure activities [1-3]. Thus, by defini-
tion, ME/CFS involves some degree of disability, defined
as “any restriction or lack (resulting from an impairment)
of ability to perform an activity in the manner or within
the range considered normal for a human being” [4].
Although fatigue may be very limiting, a range of
other symptoms common in ME/CFS such as pain and
cognitive impairment may affect function and lead to
limitation of activity and social participation. Disability
in ME/CFS (and indeed in other chronic conditions) is
multi-dimensional, and therefore generic measures of
functional status and well being characterise health sta-
tus more appropriately than symptom reporting alone.
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One of the characteristics of disabling conditions is
that their impact may be felt beyond those individuals
affected, for example by partners and family members,
who may need to spend considerable time caring for
their sick relatives, and therefore obliged to sacrifice
work and social activities. This can not only subject
them to an emotional burden but also adversely affect
their own and their families” incomes. There are some
studies demonstrating the impact of caring for chroni-
cally ill patients on the health of carers [5], but we are
not aware of any studies investigating the functional sta-
tus and well being of those who care for people with
ME/CFS. This is an important omission in our under-
standing of the impact of the disease on the family and
limits our comprehension of the needs of those caring
for people with ME/CFS (PWME).
This study aimed to measure the functional status and
well being of adults with ME/CFS and their lay carers
using a standardised reporting questionnaire, and to
identify those aspects which are most affected. We
sought also to examine the impact of different case defi-
nitions on our findings and to compare results for ME/
CFS with those achieved by people with other chronic
conditions. In addition, we investigated the relationship
between patients” scores and those achieved by their
carers.
Our main study hypotheses were that functional status
and well being of people with ME/CFS are significantly
compromised and that quality of life of carers is also
affected.
Methods
This cross-sectional study was undertaken as part of
the ME/CFS Observatory Research Programme, and
investigated the functional status and well being of
people with ME/CFS and their carers. This involved
setting up a Disease Register for the study of ME/CFS
and a series of epidemiological studies [6]. Other paral-
lel Observatory projects included investigation of the
perceptions and illness experience of patients and pro-
fessionals [7], and the social impact of this disorder
[8]. We now plan to enhance the Disease Register by
linking it to a disease specific biobank and post-mor-
tem tissue bank [9].
The sampling frame comprised 29 General Practi-
tioner (GP) practices in London, East Anglia and East
Yorkshire covering a population of over 143,000. We
searched systematically the computerised databases of
participating practices to identify patients between 18
and 65 years old who had a GP diagnosis of chronic
fatigue syndrome or a related diagnosis. We used GP
diagnosis to screen for cases, and reviewed the cases
thus identified to determine their compliance with the
diagnostic criteria adopted for the study.
Since GPs may refer to cases of ME/CFS by different
names, we screened cases that had been diagnosed by
GPs with any of the following: chronic fatigue syndrome
(CFS), ME, post-viral asthenic syndrome (PVAS), fatigue
syndrome (FS), fibromyalgia (FMS), post-infectious
encephalitis (PIE) and post-viral fatigue syndrome
(PVFS). Patients were considered as potential cases if
any of the above diagnoses appeared in their individual
electronic medical records, or if they were otherwise
referred by their GPs even in the event of they not hav-
ing been identified by the systematic search. Diagnosis
was confirmed if the patient conformed to at least one
of the following case definitions, that of the Centers for
Disease Control (CDC) in 1994, referred here as CDC-
1994 criteria [3], the clinical working case definition
established in Canada by an Expert Medical Consensus
Panel, known as the Canadian criteria [2], and the Epi-
demiological Case Definition (ECD) [10]. Assessment for
concordance with study case definition was through the
completion of a computerized research form listing clin-
ical features, which included a built-in algorithm which
determined conformity to case definitions, and hence
classified individuals as cases or non-cases, the latter
being excluded from the study. Cases were asked to
name their lay carer (usually a family member or close
friend) if they had one, and to provide them with an
invitation to take part in the study.
Data collection
Standard self-completed questionnaires requesting basic
information on personal and demographic parameters
were mailed to consenting individuals with ME/CFS,
and to their main carers.
A further, longer questionnaire was then sent to con-
firmed cases, seeking more detailed information, includ-
ing on clinical and socio-economic variables. Functional
status and well being were assessed using the standard
form of the SF-36v2™ health survey [11]. The SF-36
has been used in patients with ME/CFS in different set-
tings [12-25].
Data processing and analysis
The SF-36 health domain scales and component sum-
maries were scored using the Quality Metric scoring
software [26]. We used norm-based T scores for the
Physical (PCS) and Mental (MCS) Component summary
scales. We applied two transformations to the data on
the eight health domain scales. These included: i) trans-
formation into a norm-based score (NBS); and ii) stan-
dard transformation into a scale ranging from 0 to 100.
The scales comprising the physical and mental domains
are fully described in the SF-36 manual [11], and are
summarised below. The ‘Physical Functioning’ scale
measures performance of physical activities such as
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running, lifting and carrying groceries, climbing stairs,
walking etc. Role-Physical includes measures, for exam-
ple, of limitation or time reductions in capacity for work
or other activities, and the kind of work which can be
undertaken. ‘Bodily pain’ covers the intensity of pain,
and the extent to which pain interferes with normal
activities. ‘General Health’ relates to respondents’ views
and expectations on their health. ‘Vitality’ relates to
energy level and fatigue, and addresses subjective well-
being. ‘Social Functioning’ addresses health related
impacts on the quantity and quality of social activity.
‘Role-Emotional’ assesses the effect of mental health on
time spent at work or other activities, and the amount
and degree of care devoted to work or the performance
of other activities. ‘Mental health’ covers depression,
anxiety, loss of behavioural/emotional control and psy-
chological well being. For all domains, low scores indi-
cate poor results. We used norm-based scores in most
analyses. This metric is usually preferred as it enables
direct comparisons within and between the health
domain scales and the two component summary mea-
sures. In all cases, the expected population means are 50
and the standard deviations 10. We also present the
results for the health domain on the scale of 0 to 100,
to enable comparisons with previous studies that used
this scoring system.
All other data were entered onto an Access®-based
data entry form created specifically for the research, and
which enabled cases to be classified according to case
definition. Data from the SF-36v2™ and other study
forms were merged and exported into Stata-IV 11.1® for
Windows software, which was used for the analyses.
For descriptive purposes, we calculated the mean
scores for each health domain scale and component
summaries, by sex, both for the ME/CFS cases and for
their carers. We used the medians to describe grouped
data on standard scales (0-100 score), as we observed
that the values were not normally distributed. For com-
parison purposes we used the Student’s t-test for con-
tinuous data. We also considered minimally important
differences (MID), i.e. differences of 3 NBS points, with
the exception of ‘Role-Emotional’ and ‘Role-Physical’
where differences of 4 and 2 points respectively were
required for a difference to be considered important.
We investigated the association of scores between cases
and their carers by simple linear regression [27]. We
then contrasted the results with those for the US gen-
eral population, and gender-age and disease-specific
norms [11].
Ethical considerations
The study was approved by the Multi-Centre Research
Ethics Committee (MREC) in London (06-MRE/02/57),
the London School of Hygiene and Tropical Medicine
Ethics Committee and the local NHS Research Govern-
ance Units in London, East Anglia and East Yorkshire.
As this was an interview-based observational study no
major ethical issues were anticipated. Informed consent
was obtained in all cases. As some participants could
tire easily while completing the forms, we encouraged
them to pause when they needed to.
Study size
Participants included 170 ME/CFS cases from 18 to 65
years and 43 named carers of people with ME/CFS. This
sample size was adequate to detect SF-36 mean score
differences of 0.5 standard deviation between two sub-
groups of similar size (e.g. those complying or not with
a particular case definition, such as the Canadian cri-
teria) within the sample, with a power of 90% and a sig-
nificance level of 0.05. This yielded a total sample size
of 168. The study power was lower for multiple group
comparisons and analyses involving carers.
Results
Of 278 patients who fulfilled any of the diagnostic cri-
teria, 170 (61.1%) completed the SF-36v2™ instrument
and research questionnaire. The median age for all
respondents was 51.9 years (Interquartile range (IR) =
40.9 - 57.4). For men, the median age was 53.4 (IR =
47.6 - 60.3) and for women 49.5 (IR = 39.9 - 56.2) (P =
0.02). The median age of onset of symptoms, counted
from when patients first reported severe fatigue with
typical accompanying symptoms, was 41.5 years (IR =
30.4 to 48.3), corresponding to a median duration of
fatigue of 10 years (IR = 4.2 to 15) at the time of
recruitment. Cases included in the study were similar to
non-respondents as regards gender (P = 0.2), age-group
(P = 0.3), ethnicity (P = 0.7) and marital status (P = 0.3).
Response rates were higher in East Yorkshire (70%) than
in East Anglia (59%) and London (39%) - P < 0.01.
Table 1 describes some characteristics of cases and
their carers and shows the relationship between them.
While 78% of cases were women, the majority of carers
(57%) were men. Carers were husbands, wives or part-
ners in 81% of the cases, and a parent or child in 16%
(one professional carer was excluded from the analyses).
Table 2 summarises the patients’ scores, which are pre-
sented following norm-based and standard transforma-
tions, the latter for comparison with other studies.
Norm-based scores within the mental domain tended to
be higher than those found in the physical domain
(mean MCS = 34.1 and mean PCS = 26.8). Table 3
compares results by gender; in general men scored
lower in the mental domain (mean MCS = 30.3 and
35.2 for men and women respectively, P = 0.04), and
women in the physical domain (PCS = 30.2 and 26.0 for
men and women respectively, P= 0.02) Mean scores in
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patients with ME/CFS were consistently lower than
population means for 10 other chronic conditions
(Table 4). This was true of both sexes (Figure 1). The
pattern of higher scores in the physical component scale
than those achieved in the mental component scale was
consistent with that found in all comparison conditions
of predominantly organic origin (e.g. mean PCS = 41.1
and MCS = 47.8 for diabetes), while for depression the
opposite was true (mean PCS = 45.4 and MCS = 36.3).
Table 5 shows the scores for patients with or without
ME/CFS according to the Canadian case definition, and
shows consistently lower scores for those meeting the
Canadian definition (P<0.05 for all scales, except for
Role-Emotional). All mean differences were at least
Table 1 Demographic characteristics of the ME/CFS cases and their carers
Case definition
Demographic
variables
ME/CFS
cases
CDC-1994 Canadian ECD Carers
n % n n n n %
Gender
• Male 37 21.8 35 20 7 25 56.8
• Female 133 78.2 131 76 15 19 43.2
170 100.0 166 96 22 44 100.0
Age group
• 18-24 4 2.4 4 1 2 2 4.5
• 25-34 19 11.2 19 13 2 7 15.9
• 35-44 34 20.0 33 22 4 17 38.6
• 45-54 56 32.9 55 34 7 11 25.0
• 55-64 57 33.5 55 26 7 7 15.9
170 100.0 166 96 22 44 100.0
Ethnicity
• White British 157 92.9 154 92 19 41 97.6
• Other 12 7.1 11 3 3 1 2.4
169 100.0 165 95 22 42 100.0
Carers’ relationship with ME/CFS case
• Husband/wife/
partner 35 25 4 35 81.4
• Parent/children 7 6 7 16.3
• Other 1 1 1 2.3
43 32 4 43 100.0
Table 2 SF-36v2™ results in ME/CFS cases
SF-36 scales and summaries Norm-based scores Standard scores
Mean SDa Mean SDa Median IRb
Physical Component Summary 26.8 8.4
• Physical Functioning 27.7 10.6 30.1 24.8 25.0 10.0-45.0
• Role-Physical 25.4 8.2 19.5 20.7 12.5 0.0-31,2
• Bodily Pain 31.9 9.5 28.1 22.4 22.0 12.0-41.0
• General Health 28.3 8.0 24.9 16.7 20.0 10.0-35.0
Mental Component Summary 34.1 11.3
• Vitality 28.4 7.1 15.5 14.7 12.5 0.0-25.0
• Social Functioning 25.7 9.8 28.9 23.1 25.0 12.5-37.5
• Role-Emotional 31.3 15.1 47.2 32.5 50.0 25.0-75.0
• Mental Health 36.7 12.1 50.9 21.4 55.0 35.0-70.0
a SD = Standard Deviation; b IR = Interquartile range
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minimally important, except in women for the Physical
and Mental Component summaries, ‘Role-Emotional’
and ‘Mental Health’.
Carers
Of the 118 carers named by the patients, 51 responded
(43.2% response rate). We were able to match 43 carers
to ME/CFS cases. The median age of carers was 53.2
years (IR = 45.1 - 61.7); 52.7 years (IR = 46.4 - 58.8) in
men, and 55.1 (IR = 45.2 - 64.3) years in women (P =
0.34). Table 6 summarises scores for carers, their paired
cases and the 45-54 age population norms. The mean
physical component score was within the age norm for
the general population, but mental component scores
were lower than age norms. The scores for scales within
the physical domain were within the age population
norms, except for ‘General Health’, which was over 3
points lower. On the other hand the scores for the
scales within the mental domain were consistently lower
in the carers, in comparison with age norms. Table 7
shows the results of the regression analysis comparing
scores between cases and their carers, showing signifi-
cant associations in respect of the Mental Component
Summary score and ‘Role-Emotional’ (Figure 2). Table 8
shows that the scores within the mental health domain
were consistently lower in women carers than in male
carers; this was statistically significant for Vitality (P =
0.01) and Mental Health (P = 0.03).
Discussion
ME/CFS is a disabling condition with a high impact on
individuals and society, which causes a substantial eco-
nomic burden [28]. We measured the functional status
and well being of a well characterised sample of indivi-
duals with ME/CFS and their careers, using SF-36, a
widely used and well-validated instrument, which pro-
vides generic (i.e. universally-valued, and not specific to
age, disease or condition or treatment) measures of dis-
ease impact on physical, physiological, social functioning
and roles [11] Generic instruments best capture the ‘total
burden of disease’ by expressing the impact of the disease
on functioning and well being. Therefore, unlike disease-
specific measures, they can be adequately used for com-
parisons between people with ME/CFS and healthy indi-
viduals and those with a range of other diseases [29].
While SF-36 version 2 represents an improvement on its
predecessor, it is still meaningful to compare results
which use different versions of this instrument [11].
The use of norm-based scores allowed comparisons
between scales and component summaries, and helped
identify which aspects of quality of life are most affected.
The physical and mental health summary measures pro-
vide convenient ways to quantify physical and mental
health status. Individual-based scores below 40 and
group mean scores below 47 may indicate impairment of
function. For example, low scores in the physical compo-
nent scale may relate to limitations in self-care and
reduced well-being. Low scores in the mental component
scale may relate to frequent psychological distress, and
emotionally-driven social and role disability [11].
The scores for the Physical and Mental Health Compo-
nent summaries and the scales within each of these
domains were considerably and consistently lower in peo-
ple with ME/CFS, when contrasted with individuals with a
range of other chronic diseases. By using normalized
scores, we were able to show that the scores within the
physical domain were even lower than those in the mental
domain, although all scales showed very low values. This
demonstrates that ME/CFS is not only physically disabling,
but also has a significant impact on mental health.
Table 3 SF-36v2™ results in ME/CFS patients by gender
Norm-based scores
SF-36 scales and summaries Males (n =
37)
Females (n =
133)
P-value1
mean SDa mean SDa
Physical Component Summary 30.2 8.8 26.0 8.2 0.023
• Physical Functioning 31.5 13.2 26.7 9.5 0.026
• Role-Physical 25.3 9.2 25.4 7.9 0.840
• Bodily Pain 33.8 10.9 31.4 9.11 0.264
• General Health 28.4 9.7 28.3 7.5 0.993
Mental Component Summary 30.3 11.9 35.2 11.0 0.040
• Vitality 26.4 6.8 29.1 7.1 0.040
• Social Functioning 25.9 11.2 25.7 9.4 0.853
• Role-Emotional 28.5 17.2 32.0 14.5 0.364
• Mental Health 34.0 13.8 37.4 11.5 0.166
a SD = Standard Deviation
1 t-test. For all P-values lower than 0.05, except for the vitality score, the
difference in means reached the value considered minimally important.
Table 4 PCS and MCS mean scores for ME/CFS cases and
selected SF-36 disease-specific norms
Disease Physical
Component
Summary
Mental
Component
Summary
mean SDa mean SDa
ME/CFS (n = 170) 26.8 8.4 34.1 11.3
Back pain/sciatica (n = 2648) 45.7 10.7 47.6 11.1
Cancer (except skin) (n = 253) 40.9 9.9 47.6 10.6
Depression (n = 942) 45.4 11.6 36.3 11.9
Diabetes (n = 1011) 41.1 11.2 47.8 11.5
Heart disease (n = 691) 38.9 10.0 48.3 10.7
Limited use of arm(s)/leg(s) (n = 605) 39.0 11.5 46.7 12.2
Lung disease (n = 328) 38.3 10.8 45.6 11.5
Osteoarthritis (n = 1013) 38.6 10.1 48.0 10.9
Rheumatoid arthritis (n = 514) 40.0 10.6 47.8 11.3
Vision impairment (n = 628) 44.0 11.6 45.8 11.9
a SD = Standard Deviation
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Physical Health Component summaries at the levels
found in our study (mean score 26.8) have been shown
to relate to an inability to climb one flight of stairs in
over 90% of those with similar scores, with three-
quarters of those with this scoring level having difficul-
ties at work, with over half needing to reduce the
amount of time spent at work, and two thirds rating
their health as ‘fair’ or ‘poor’ [11]. This score
0
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Figure 1 SF-36v2™ scores in men and women with ME/CFS, other health conditions or healthy. RA - Rheumatoid arthritis; PF - Physical
Functioning, RP - Role-Physical, BP - Bodily pain, GH - General Health, VT - Vitality, SF - Social Functioning, RE - Role-Emotional, MH - Mental health.
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corresponds to around the 5th percentile of the US gen-
eral population, and is lower than the 25th percentiles
of 10 other chronic diseases we used for comparison
purposes. The lowest observed mean score was for
‘Role-Physical’, indicating limitations in functionality for
these patients. The values found for this scale are com-
parable to the 25th percentiles of those with limited use
of arm(s) and leg(s), and are lower than the 25th percen-
tiles of those with 9 other conditions.
The mean Mental Health Component summary of
34.1 is comparable to the mean score of those with
depression (MID lower than 3), and to the 25th percen-
tile of those with lung disease. It is lower than the 25th
percentile of all the other comparison conditions, and
corresponds to around the 9th percentile of the general
population. The highest values in this domain were for
the ‘Mental Health’ scale, but these were still very low,
equivalent to around the 10th percentile of the general
population.
The ‘Role-Physical’ scale was one the most affected of
all, suggesting this could be a suitable outcome measure
in ME/CFS. The vitality scale has been widely used in
ME/CFS research, as it is directly related to the percep-
tion of low energy levels typical of those with chronic
fatigue. This scale has often presented strikingly low
results in people with ME/CFS, on a ‘0 to 100’ score,
and this might have helped to reinforce its suitability as
an outcome measure in this disorder. In our study, this
was 15.5, representing the lowest of all scores. Although
still low when normalized scores were used, the ‘Vitality’
score ranked as the 4th highest score among the 8 health
domains scales (the highest score was for Mental
Table 5 SF-36v2™ results in ME/CFS patients according to conformity to the Canadian diagnostic criteria
SF-36 scales and summaries Patients with Canadian diagnostic
criteria
Patients without Canadian diagnostic
criteria
Males
(n = 20)
Females
(n = 76)
Total
(n = 96)
Males
(n = 15)
Females
(n = 55)
Total
(n = 70)
Comparison of total mean
scores
mean SDa mean SDa mean SDa mean SDa mean SDa mean SDa Mean difference1 P- value2
Physical Component Summary 26.2 7.0 23.5 7.1 24.1 7.2 34.5 8.1 25.8 8.1 30.6 8.7 6.5 0.000
• Physical Functioning 26.9 11.6 24.1 8.2 24.7 9.0 36.2 13.3 30.4 10.7 31.8 11.5 7.1 0.000
• Role-Physical 21.1 5.1 22.9 5.2 22.5 5.2 30.2 10.7 29.1 9.9 29.3 10.0 6.8 0.000
• Bodily Pain 29.4 8.6 30.0 8.3 29.9 8.4 38.1 10.7 33.2 10.2 34.3 10.3 4.4 0.002
• General Health 23.9 6.5 26.6 6.6 26.0 6.6 32.7 8.7 30.6 8.5 31.0 8.5 5.0 0.000
Mental Component Summary 25.6 11.2 34.3 11.4 32.5 11.9 35.7 10.4 35.1 11.0 36.0 10.4 3.5 0.023
• Vitality 24.3 6.1 27.3 6.3 26.6 6.3 28.8 7.2 31.5 7.4 30.9 7.4 4.3 0.000
• Social Functioning 20.5 7.1 23.7 8.0 23.3 7.9 32.8 12.3 28.4 10.8 29.4 11.2 6.1 0.000
• Role-Emotional 24.1 17.3 31.7 14.6 29.6 15.3 33.1 15.0 33.0 14.5 33.1 14.5 3.5 0.076
• Mental Health 28.5 12.4 36.2 12.0 34.6 12.4 40.6 12.8 38.9 11.3 39.3 11.6 4.7 0.007
aSD = Standard Deviation
1 Patients without Canadian criteria - Patients with Canadian criteria
2 t-test comparing totals of SF-36v2TM in patients, who conform or not with Canadian diagnostic criteria
Table 6 SF-36v2™ results of carers, ME/CFS cases and standard general population norms
SF-36 scales and summaries Carer’s scores Paired case’s scores General population
45-54 years-old’s scores
Mean SDa Mean SDa Mean SDa
Physical Component Summary 49.1 9.5 25.7 9.1 49.7 9.1
• Physical Functioning 48.9 10.3 26.3 11.1 50.1 8.7
• Role-Physical 47.8 10.0 23.2 6.4 50.4 8.9
• Bodily Pain 50.1 10.8 32.3 11.8 49.3 9.1
• General Health 45.6 12.1 27.3 8.5 49.8* 9.4
Mental Component Summary 45.4 12.6 32.6 11.6 50.6* 9.0
• Vitality 46.1 12.0 26.4 6.0 50.6* 9.2
• Social Functioning 46.3 12.6 22.6 9.3 50.1* 9.2
• Role-Emotional 45.7 11.7 30.6 16.0 50.8* 8.8
• Mental Health 47.1 12.5 35.8 12.9 50.2* 7.9
aSD = Standard Deviation
*Minimally important differences in scores observed between carers and general population scores
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Health). This indicates that lack of energy in itself may
well not be the most disabling feature of ME/CFS. It
also illustrates the inappropriateness of the ‘0 to 100’
score for comparing scales. ‘Vitality’ scores have inher-
ently low values, as illustrated by the finding for the US
general population, where the mean for this score is
58.3. In comparison, the mean score for ‘Role-Pyia’ in
the same population is 82.5, with scores for the remain-
ing scales varying between 75.0 (’Mental Health’) and
87.4 (’Role-Emotional’).
We have shown that the quality of life of those caring
for people with ME/CFS is also affected. In most cases,
their scores were lower than those of healthy individuals
of the same age group. Interestingly, the Mental Health
Component summary and scales within this domain
were more sharply reduced, compared with the sum-
mary and scales within the Physical Component. In
addition, the significant correlations demonstrated
between the Mental Health Summary and ‘Role-Emo-
tional’ scores of patients and their carers suggest that
those patients who are less able to carry out emotional
roles and whose mental health is more affected repre-
sent a greater burden to their carers. These findings
may demonstrate the intensity of the emotional pres-
sures on those caring for people with ME/CFS.
Previous studies have shown that a considerable
impact on the functional status and well-being or the
quality of life of people with ME/CFS [12-14,16,17
,19,21,24,25,30-32]. These studies varied in relation to
the methods used, including the reference population,
how cases were ascertained, and how quality of life has
been measured. When SF-36 was used, the scales scores
were not normalized, which made comparisons difficult.
However, we have also presented our results using the
standard scoring system (0-100 scores), to enable com-
parisons with these previous studies. While low scores
were consistently found previously [19,22,24,25,33], they
were not as low as in our study. Possible explanations,
other than differences in populations and methods,
include the specificity of the case definitions we used,
which might have excluded cases that would have been
positive if other, more complacent diagnostic criteria
were used. The fact that the scores of cases meeting the
Canadian criteria were consistently lower than those not
meeting the criteria further suggests that diagnosis spe-
cificity is related to disease severity, and that diagnostic
criteria such as the Canadian may be more appropriate
for research studies investigating risk factors and disease
biomarkers.
Study strengths and limitations
Our study strengths include the large sampling frame,
selection of participants from wide geographic areas,
well characterised patients, standardised recruitment
procedures and the use of a well validated instrument to
measure functional status and well being. The response
rate for carers was not particularly high, but all scores
were similar in patients whose carers completed the SF-
36 and those who did not (data not shown), giving some
indication that participation was unlikely to have
selected a particular sub-group of carers. Our compari-
sons were made with references based on the US popu-
lation. Although comparisons would ideally have been
made with the population in the same UK regions, large
US studies provide reliable and readily available popula-
tion norms, including for the general population, speci-
fic diseases, gender, and age groups. In addition, the SF-
36 instrument has been widely available internationally
[11], including in the UK [34], where general population
scores have been similar and in some cases slightly
higher than those in the US. The comparisons of scores
with those with other chronic diseases and the healthy
population were based on different age groups, i.e. 18-
64 years in our study and 18 and over in the SF-36
population survey. As we would expect population
scores to be increased by the exclusion of elderly indivi-
duals, restriction of the comparison to those under 65
only would, if anything, tend to show a more dramatic
contrast between those with ME/CFS and other disease
population groups. The large differences between ME/
CFS patients and those in other groups reassure us that
the differences are genuine, and would be expected to
remain if we used controls from the same geographical
area.
The results of the study highlight the disabling nature
of ME/CFS. However, the lack of biomarkers and the
fluctuating nature and lack of specificity of symptoms
makes disease characterisation and disability assessment
challenging. Our study supports the potential value of
SF-36 as an instrument to characterise incapacity in
people with ME/CFS, and particularly that of specific
Table 7 Association between SF-36v2™ mean scores in
ME/CFS cases and their respective carers
SF-36 scales and summaries Linear regression analysis results
P value Adjusted R-squared
Physical Component Summary 0.44 0.009
• Physical Functioning 0.89 0.024
• Role-Physical 0.88 0.024
• Bodily Pain 0.74 0.022
• General Health 0.84 0.023
• Mental Component Summary 0.03 0.080
• Vitality 0.23 0.011
• Social Functioning 0.72 0.021
• Role-Emotional 0.03 0.093
• Mental Health 0.10 0.041
aSD = Standard Deviation
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scales, such as the ‘Role-Physical’. They may represent a
reliable outcome measure indicating case severity for
use in observational and interventional studies. How-
ever, as the scales are based on patient report, they
should ideally be used in combination with other instru-
ments providing objective outcome measurements of
physical [35] and neuro-cognitive abilities [36]. A good
example of an objective measure of disability is that of
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Figure 2 “Mental Health Summary” and “Role-Emotional” scores from ME/CFS cases and their carers. MHS - Mental Health Summary; RE
- Role-Emotional.
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cardiopulmonary exercise testing with measurement of
VO2 max, anaerobic threshold and maximal heart rate
and respiration. This test has shown abnormal results in
people with ME/CFS [35], and could perhaps be used
more often in disability assessments, in combination
with instruments based on patient report such as the
SF-36.
Conclusions
Quality of life is inversely related to distress, disability
and loss of function, and is associated with the ability of
individuals to remain active and perform roles in
society. A major goal of people with chronic diseases is
to achieve effectiveness in life and to preserve function
and well-being. However, people with ME/CFS are by
and large failing to achieve these goals, and their carers’
emotional well being is also being affected.
Disability assessment in PWME remains a challenge,
as the disabling nature of the condition is not always
immediately apparent. Nevertheless, recognition of the
level of disability faced by these individuals is essential
for planning support services that adequately meet their
needs. Measures of quality of life outcomes are also
essential both for clinical practice and research, particu-
larly in the assessment of interventions. Generic instru-
ments such as SF-36 and individual scales such as ‘Role-
Physical’ may provide meaningful ways to assess the
functional ability and wellness of people with ME, espe-
cially when combined with objective measures of func-
tional status, thus enhancing the capacity to address the
burden of disability experienced by patients and carers.
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